P Jedlicka
Overview
Explore the profile of P Jedlicka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
706
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sechler M, Parrish J, Birks D, Jedlicka P
Oncogene
. 2017 Mar;
36(29):4150-4160.
PMID: 28319067
Ewing Sarcoma is the second most common solid pediatric malignant neoplasm of bone and soft tissue. Driven by EWS/Ets, or rarely variant, oncogenic fusions, Ewing Sarcoma is a biologically and...
2.
Karuppuchamy T, Behrens E, Gonzalez-Cabrera P, Sarkisyan G, Gima L, Boyer J, et al.
Mucosal Immunol
. 2016 Apr;
10(1):162-171.
PMID: 27049060
The sphingosine-1-phosphate receptor-1 (S1P) agonist ozanimod ameliorates ulcerative colitis, yet its mechanism of action is unknown. Here, we examine the cell subsets that express S1P in intestine using S1P-eGFP mice,...
3.
Aherne C, Saeedi B, Collins C, Masterson J, McNamee E, Perrenoud L, et al.
Mucosal Immunol
. 2015 May;
8(3):699.
PMID: 25943416
No abstract available.
4.
Aherne C, Saeedi B, Collins C, Masterson J, McNamee E, Perrenoud L, et al.
Mucosal Immunol
. 2015 Apr;
8(6):1324-38.
PMID: 25850656
Central to inflammatory bowel disease (IBD) pathogenesis is loss of mucosal barrier function. Emerging evidence implicates extracellular adenosine signaling in attenuating mucosal inflammation. We hypothesized that adenosine-mediated protection from intestinal...
5.
Parrish J, Sechler M, Winn R, Jedlicka P
Oncogene
. 2013 Dec;
34(2):257-62.
PMID: 24362521
Ewing Sarcoma is a biologically aggressive bone and soft tissue malignancy affecting children and young adults. Ewing Sarcoma pathogenesis is driven by EWS/Ets fusion oncoproteins, of which EWS/Fli1 is the...
6.
Gustafson C, Higbee D, Yeckes A, Wilson C, de Zoeten E, Jedlicka P, et al.
Mucosal Immunol
. 2013 Sep;
7(3):467-77.
PMID: 24045575
The absence of immunoglobulin A (IgA) in the intestinal tract renders young infants highly susceptible to enteric infections. However, mediators of initial IgA induction in this population are undefined. We...
7.
Collins C, Aherne C, Yeckes A, Pound K, Eltzschig H, Jedlicka P, et al.
Mucosal Immunol
. 2013 Jan;
6(5):960-71.
PMID: 23321985
Inflammatory bowel disease (IBD) is a chronic inflammatory condition thought to reflect a failure of the enteral immune system to adequately regulate itself. Inflammatory stress drives upregulation of heat-shock proteins...
8.
Linger R, Cohen R, Cummings C, Sather S, Migdall-Wilson J, Middleton D, et al.
Oncogene
. 2012 Aug;
32(29):3420-31.
PMID: 22890323
Non-small cell lung cancer (NSCLC) is a prevalent and devastating disease that claims more lives than breast, prostate, colon and pancreatic cancers combined. Current research suggests that standard chemotherapy regimens...
9.
Jedlicka P, Steinbauerova V, Simek P, Zahradnickova H
Comp Biochem Physiol A Mol Integr Physiol
. 2012 Feb;
162(1):51-8.
PMID: 22357169
Aphids are important plant phloem-sucking pests and detailed knowledge about the hormonal control of their metabolism can potentially contribute to the development of methods for their management. The insect metabolism...
10.
Farabaugh S, Micalizzi D, Jedlicka P, Zhao R, Ford H
Oncogene
. 2011 Jun;
31(5):552-62.
PMID: 21706047
Six1 is a critical regulator of embryonic development that requires interaction with the Eya family of proteins (Eya1-4) to activate the transcription of genes involved in neurogenesis, myogenesis and nephrogenesis....